FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, namely to a pharmaceutical formulation containing a compound of formula I and its pharmaceutically acceptable salts
wherein R1, R2, R3, R4, R5 and R6 are independently specified in a group consisting of H, SO3H and PO3H2, provided at least two of R1-R6 are specified in SO3H and PO3H2; and a delivery agent representing a carboxypolymethylene polymer.
EFFECT: invention provides higher effectiveness of the composition and improved intestinal absorption of the medicinal preparation.
20 cl, 26 dwg, 2 ex
| Title |
Year |
Author |
Number |
| METHOD AND COMPOSITIONS FOR TREATMENT OF ALLERGIC RESPONSES AT LATE STAGE AND INFLAMMATORY DISEASES |
1998 |
|
RU2209624C2 |
| POLYSULFATED GLYCOSIDES AND THEIR SALTS |
2005 |
- Kusmann Janosh
- Kuruts Ishtvan
- Medd'Esh Gabor
- Bodor Nikolas
|
RU2413734C2 |
| METHOD AND COMPOSITION FOR ASTHMA TREATMENT |
1996 |
- Akhmed Takhir
- Broder Sehmjuel'
- Visnant Dzhon K.
|
RU2179445C2 |
| METHOD OF TREATMENT AND/OR PREVENTION OF ASTHMA, ASTHMA AGGRESSION, ALLERGIC ASTHMATIC DISORDERS AND/OR RESPIRATORY DISORDERS ASSOCIATED WITH MICROBIOTA |
2019 |
- Vercelli, Donata
- Pasquali, Christian
- Pivniouk, Vadim
- Martinez, Fernando
- Bauer, Jacques
|
RU2800051C2 |
| NIMESULIDE-CONTAINING SUSTAINED-RELEASE COMPOSITIONS |
2000 |
- Singkh Amardzhit
- Dzhejn Radzhesh
|
RU2238087C2 |
| COMPOSITIONS AND METHODS FOR TREATING CANCER |
2017 |
|
RU2770081C2 |
| INHALATION COMPOSITIONS CONTAINING MONTELEUKAST ACID AND PDE-4 INHIBITOR OR INHALATION CORTICOSTEROID |
2008 |
|
RU2470639C2 |
| DIOXOANTHRACENE SULPHONATE DERIVATIVES |
2008 |
- Karlino Stefano
- Di Napoli Alessandro
|
RU2482109C2 |
| COMBINATION OF THERAPEUTICAL AGENTS (FOR EXAMPLE, CHLOROPROMAZINE AND PENTAMIDINE) FOR TREATING NEOPLASTIC DISORDERS |
2001 |
- Borajsi Aleksis
- Kejt Kertis
- Fouli Majkl A.
- Stokvell Brent R.
|
RU2286769C2 |
| CELASTROL AND DERIVATIVES THEREOF FOR TREATING OBESITY |
2015 |
- Mazitschek, Ralph
- Oezcan, Umut
|
RU2706239C2 |
